|
Volumn 102, Issue 7, 2008, Pages 694-698
|
Revising antimalarial drug policy in Central America: experience in Panama
|
Author keywords
Antimalarials; Central America; Drug resistance; Malaria; Panama; Plasmodium falciparum
|
Indexed keywords
ANTIMALARIAL AGENT;
CHLOROQUINE;
FANSIDAR;
FOLIC ACID ANTAGONIST;
MEROZOITE SURFACE PROTEIN 2;
PRIMAQUINE;
ACUTE HEPATITIS;
ADULT;
ADULT RESPIRATORY DISTRESS SYNDROME;
ARTICLE;
AUTOPSY;
BRAIN MALARIA;
CASE REPORT;
CENTRAL AMERICA;
CLINICAL FEATURE;
DISEASE SEVERITY;
DISSEMINATED INTRAVASCULAR CLOTTING;
DNA SEQUENCE;
FATALITY;
FEMALE;
GENE MUTATION;
GENOTYPE;
HEALTH CARE POLICY;
HUMAN;
HUMAN TISSUE;
INFECTION RESISTANCE;
MALARIA FALCIPARUM;
MALE;
NONHUMAN;
NUCLEOTIDE SEQUENCE;
PANAMA;
PARASITE VIRULENCE;
PARASITEMIA;
PLASMODIUM FALCIPARUM;
POLYMERASE CHAIN REACTION;
PRESCHOOL CHILD;
PUBLIC HEALTH;
ADULT;
ANIMALS;
ANTIMALARIALS;
CHILD, PRESCHOOL;
CHLOROQUINE;
DNA, PROTOZOAN;
DRUG RESISTANCE;
FATAL OUTCOME;
FEMALE;
GENOTYPE;
HEALTH POLICY;
HUMANS;
MALARIA, FALCIPARUM;
MALE;
MUTATION;
PANAMA;
PLASMODIUM FALCIPARUM;
PREGNANCY;
PLASMODIUM FALCIPARUM;
|
EID: 44749084648
PISSN: 00359203
EISSN: None
Source Type: Journal
DOI: 10.1016/j.trstmh.2008.03.012 Document Type: Article |
Times cited : (15)
|
References (8)
|